Integrated venture, nonprofit platform, and research arm delivering health-only expertise across human, health tech, and animal health, plus an animal-health franchise with Mars and links to ARPA-H initiatives. With a disciplined investment approach, the team drives value for both founders and investors.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Centered on relocating early-phase companies—especially from Latin America—to Tulsa via investments and coordinated city-building programs, with growth measured by financial returns and local employment outcomes. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Venture studio and fund that co‑incubates with LifePoint executives, giving startup ventures direct access to a $50B+ health system for pilot deployment, real‑world validation, and underserved population focus. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Acts as a VC and venture studio—co-founds emerging ventures with 25–30% of capital, assembles top‑1% specialists, and builds national‑capability defense, industrials, and bio‑infrastructure companies with corporate partners. The firm continues to build its presence across the venture capital landscape.
Invests very early (seed, $1–3M) with a solo GP enabling rapid decisions, leveraging an operator-heavy LP network for sourcing and delivering data-driven diagnostics plus structured playbooks to find PMF. The firm continues to build its presence across the venture capital landscape.
Invests at idea/inception stage before pre-seed—often pre-company—focused exclusively on developer-first enterprise infrastructure, acting as a cofounder-like partner and running programs that train early founders in bottoms-up growth. With a disciplined investment approach, the team drives value for both founders and investors.
Selective firm investing where it has an unfair advantage, running a company-creation platform with 22 EIRs and a 90+ C-suite council delivering market insights to healthcare, data+AI and cyber defense. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
